SINGAPORE – There are many portfolio supervisors who will recommend that it is helpful to add a couple of safe stocks when making your stock investing and investing portfolio. A safe stock is one that can flourish even in currency downturns. Protection stocks not only provide security for your portfolio, but also work as a support in the midst of bear markets. The healthcare industry is considered a protective industry, as healthcare is a necessary part of everyday existence.
So having healthcare stocks to deal with in your portfolio might be a smart idea. All things considered, there are two Singapore healthcare stocks that have a good growth rate.
ISEC Healthcare Ltd
International Specialist Eye Center (ISEC) is listed on SGX in 2014. The company is at Centrepoint South Mid Valley Kuala Lumpur, Penang Jalan Burma and Lee Hung Ming Eye Center are centers of excellence in ophthalmology, specifically in clinical care, teaching and research.
The group provides expert therapeutic ophthalmology benefits through its system of four eye centers in Malaysia and one at Gleneagles Hospital in Singapore. In 2016, the company expanded its administrations to incorporate general restorative administrations by obtaining the JLM Companies, which contains four facilities in the heart of Singapore.
The system has worked admirably, so stock advice is to keep it in your portfolio. In 2017, the organization revealed a 20% increase in revenue and a 22% increase in net profit. It also started 2018 well, with first-quarter revenue up 14% while profit grew year-over-year.
This was attributed to an increased number of patients at their current centers, likely due to the recently obtained referral expansion from their facility system.
The company has also said a couple of times that it plans to expand its territorial presence locally in China and Vietnam, where the market for eye administrations is considerably larger than Malaysia and Singapore.
With its perfect no-commitment asset statement and S$27 million in real money, the organization surely has the budgetary power to make further acquisitions or establish a hub in its target markets. Labor income is expanding more reliably along with your net profit. This can provide the organization with the accounts to make further acquisitions or to reward investors through profits or offer buybacks.
Furthermore, at a cost of shares of S$0.29 (in compounding season), the organization is estimated at just 17.7 times its annualized profit and 2.23 times its book value. Above that, its offerings have a trailing earnings yield of 4.1%, the third-highest performance among human services stocks in Singapore.
Raffles Medical Group
Raffles Medical is the second largest registered healthcare manager in Singapore. It owns a system of general practice facilities and a medical center in Singapore. The company has perhaps extraordinary compared to other development track records in Singapore.
This Singapore stock pick started in 1976 with just two centers. Since then, the company has developed at a rapid pace and now has a network of centers located in Singapore and other countries such as China, Japan, Vietnam and Cambodia.
The company has also initiated plans for two new healing centers in China. They are a 700-bed medical center in Chongqing and a 400-bed healing center in Shanghai. It also added a 20-story expansion to its existing Singapore health center in January this year, increasing its professional services and expanding its bed and facility space limit.
Remarkably, Raffles Medical Equity has achieved this great development largely through its money earned from the assignments. In 2017, the organization produced around S$83 million in income from work.
Despite the huge investments required for the two new healing centers, Raffles Medical, as of March 31, 2018, used only S$72 million of liability and accumulated S$94 million, giving it a net monetary position of S$22 million.
Would-be financial specialists should also be pleased to learn that the company’s Singapore stock trading has taken a significant beating in the market over the past few years. Offerings are trading at just S$1.01 a piece, nearly 30% below its peak. Market members have worried about the top concern’s stagnating growth for the past few years due to market submergence in its core market in Singapore.
Raffles Medical shares as of now have a price-earnings ratio of 25.2, a price-to-book ratio of 2.4 and a return of 2.2%. These are attractive valuations, and long-term investors who will take care of any dental issues at their new healing facility will likely be compensated.
I hope you found this stock update article helpful. Stay up to date with our Singapore stocks blog for the best Singapore stocks stocks and investment signals.
Leave a comment in the comment section. Thanks!!